Американское общество гирудотерапии

GILZ: a new link between the hypothalamic pituitary adrenal axis and rheumatoid arthritis?

Review published in Immunology and cell biology (2014)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewРазработка лекарственных препаратовБезопасность и инфекционный контрольEades LE et al. · Immunology and cell biology, 2014

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis is an important regulator of the stress response. In healthy individuals, the HPA axis maintains an equilibrium, ensuring that endogenous glucocorticoid (GC) levels remain within the normal range. However, hypofunction of the HPA axis may have a role in the development of inflammatory diseases, such as rheumatoid arthritis (RA). Glucocorticoid-induced leucine zipper (GILZ) is an anti-inflammatory protein, the expression of which is upregulated by GC. Although GILZ mediates the anti-inflammatory effects of GC, it may not be associated with the adverse effects that are frequently caused by exogenous GC administration. This has raised interest in GILZ potentiation as a therapeutic approach in diseases such as RA, which may mimic the anti-inflammatory effects of GC without causing harmful side effects. This review will outline the involvement of the HPA axis in RA, as a prelude to highlighting emerging evidence regarding the role of GILZ in inflammation control and RA.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAnimalsArthritis, RheumatoidGlucocorticoidsHumansHypothalamo-Hypophyseal SystemInflammationLeucine ZippersPituitary-Adrenal System

Резюме

The hypothalamic-pituitary-adrenal (HPA) axis is an important regulator of the stress response.

Почему это важно для гирудотерапии

This review explores the role of the hypothalamic-pituitary-adrenal axis and the anti-inflammatory protein Glucocorticoid-induced leucine zipper (GILZ) in rheumatoid arthritis, discussing GILZ potentiation as a strategy to mimic glucocorticoid anti-inflammatory effects without harmful side effects. The article discusses endocrine pathways, GILZ expression regulation by glucocorticoids, and GILZ as an emerging target for inflammation control in RA. The abstract makes no reference to leeches, hirudotherapy, or leech-derived molecules. Consequently, its relevance to the American Society of Hirudotherapy is entirely indirect, limited to the shared clinical context of identifying new anti-inflammatory treatment strategies.

Цитирование

GILZ: a new link between the hypothalamic pituitary adrenal axis and rheumatoid arthritis?

Eades LE et al. · Immunology and cell biology, 2014

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.